Charles Gillman discloses 5.1% TransAct (TACT) stake worth about $2.45M
Rhea-AI Filing Summary
Charles M. Gillman reports beneficial ownership of 521,841 shares of TransAct Technologies common stock, representing 5.1% of the company’s outstanding shares as of April 30, 2026. The aggregate purchase price for these shares is approximately $2,453,646, excluding brokerage commissions.
The stake is held for investment and acquired in the ordinary course of business, not with the stated purpose of gaining control of the company. Gillman retains sole voting and dispositive power over all reported shares. He may buy more or sell some or all of the position over time, depending on market and investment considerations, and may communicate with other shareholders, management, and the board about TransAct’s operations or potential corporate actions, including possible transactions or board or management changes.
Positive
- None.
Negative
- None.
Insights
A 5.1% investment stake in TransAct creates room for future engagement but no stated control plan.
Charles M. Gillman has accumulated 521,841 TransAct Technologies shares, or 5.1% of outstanding stock as of April 30, 2026, for about $2,453,646. He holds sole voting and dispositive power, meaning he alone decides how these shares are voted and when they are sold.
The position is described as an investment acquired in the ordinary course, without a current plan to control the company. However, the disclosure notes he may discuss operations and potential actions such as additional share acquisitions, possible extraordinary corporate transactions, or changes in the board or management. Future impact will depend on whether he pursues any of these ideas.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
percent of class financial
extraordinary corporate transaction financial
dispositive power financial
FAQ
How large is Charles M. Gillman’s stake in TransAct Technologies (TACT)?
What voting and dispositive powers does Charles M. Gillman have over TACT stock?
What is Charles M. Gillman’s stated purpose for investing in TransAct Technologies (TACT)?
Could Charles M. Gillman push for changes at TransAct Technologies (TACT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.